Authors
Loading...
Preclinical study reveals that TRPA1 facilitates MrgprD activation to drive cold allodynia in nerve injury models, highlighting a potential therapeutic target for neuropathic pain.
Wang et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: